NAMI - The Nation's Voice on Mental Illness Home | About NAMI | Contact Us | En Espanol  | Donate  
Inform YourselfFind SupportTake Action
Find
  Advanced Search  
 

Sign In
myNAMI
Communities
Register and Join
Donate
What's New
State & Local NAMIs
Advocate Magazine
NAMI Newsroom
NAMI Store
NAMIWALKS
National Convention
Special Needs Estate Planning
NAMI Travel

Home

Print this page
Graphic Site
Log Out
 | Print this page | 
 | 

CATIE, Large Study on Schizophrenia, Released

CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) is the first large scale attempt to compare five different medications used to treat people living with schizophrenia.   The study included both newer (atypical) and one older anti-psychotics.  The study was funded by the National Institute of Mental Health (NIMH) and included 1400 subjects.  The duration of the study was 18 months.

NAMI has made available several tools that can assist advocates in addressing concerns related to CATIE. 

NAMI's statement on CATIE

Ten Questions on CATIE

CATIE Raises More Questions than It Answers

The CATIE Report as Published in the New England Journal of Medicine

NIMH Perspective on Antipsychotic Reimbursement: Using Results from CATIE

 | Print this page | 
 | 


Join NAMI today!

When you become a member of NAMI, you become part of America's largest grassroots organization dedicated to improving the lives of persons living with serious mental illness. And now you can join online.

Home  |  myNAMI  |  About NAMI  |  Contact Us  |  Jobs  |  SiteMap

Copyright © 1996 - 2009 NAMI. All Rights Reserved.